Literature DB >> 17952559

Genetics in the context of thrombophilia.

Elizabeth A Varga1.   

Abstract

Traditionally, genetics is defined as the study of single-gene and chromosomal disorders, inheritance patterns and variation in organisms. Recent developments in molecular genetics have increased our understanding of how genetic traits contribute to common disease. As a result, it is anticipated that genetic technologies will increasingly be integrated into medical practice. Therefore, it is essential that all medical practitioners have an understanding of basic genetic concepts and terminology. The goal of this manuscript is to provide an overview of genetic and genomic terminology in order that health care practitioners may gain a better appreciation of how these concepts may be applied to medical practice. Factor V Leiden, a genetic alteration that results in a hypercoagulable state, is utilized to explore relevant genetic concepts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17952559     DOI: 10.1007/s11239-007-0055-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  7 in total

Review 1.  Medication selection by genotype: How genetics is changing drug prescribing and efficacy.

Authors:  Cynthia A Prows; Daniel R Prows
Journal:  Am J Nurs       Date:  2004-05       Impact factor: 2.220

2.  A single genetic origin for a common Caucasian risk factor for venous thrombosis.

Authors:  A Zivelin; J H Griffin; X Xu; I Pabinger; M Samama; J Conard; B Brenner; A Eldor; U Seligsohn
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

3.  Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Authors:  P M Ridker; J P Miletich; C H Hennekens; J E Buring
Journal:  JAMA       Date:  1997 Apr 23-30       Impact factor: 56.272

4.  Activated protein C resistance (FV:Q506) and pregnancy.

Authors:  P G Lindqvist; P J Svensson; K Marsaál; L Grennert; M Luterkort; B Dahlbäck
Journal:  Thromb Haemost       Date:  1999-04       Impact factor: 5.249

5.  Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.

Authors:  J Corral; J A Iniesta; R González-Conejero; M Villalón; V Vicente
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  Factor V Leiden protects against blood loss and transfusion after cardiac surgery.

Authors:  Brian S Donahue; David Gailani; Michael S Higgins; Davis C Drinkwater; Alfred L George
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

7.  Factor V Leiden and the risk for venous thromboembolism in the adult Danish population.

Authors:  Klaus Juul; Anne Tybjaerg-Hansen; Peter Schnohr; Børge G Nordestgaard
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.